<DOC>
	<DOCNO>NCT02737449</DOCNO>
	<brief_summary>The primary objective prospectively study comparative effectiveness comparative safety approve therapy RA Japanese cohort patient treated rheumatologist . Specifically effectiveness safety newer class dosages disease modify anti-rheumatic drug ( DMARDs ) ; e.g . high dose methotrexate ( MTX ) , non-tumor necrosis factor ( TNF ) biologics , Janus Kinase ( JAK ) inhibitor ) compare anti-TNF biologics .</brief_summary>
	<brief_title>Corrona Japan Rheumatoid Arthritis ( RA ) Registry</brief_title>
	<detailed_description>The design prospective , multicenter , non-interventional , observational study patient RA newly prescribe MTX , biologic DMARD , JAK inhibitor time enrollment registry . The drug prescribe per physician 's decision precede decision enroll patient registry . Longitudinal follow-up data obtain via Corrona Questionnaires complete patient treat rheumatologist routine clinical practice . The Enrollment Follow-Up Questionnaires capture data patient demographic , target medical history include history prior treatment RA , smoke history , disease duration , disease severity , disease activity , laboratory result , comorbidities , hospitalization target safety event . The study also monitor range clinical effectiveness , patient report outcome ( PROs ) , health economic , safety outcome , include infection , malignancy cardiovascular event , among safety outcome . Standard component European League Against Rheumatism ( EULAR ) ( Disease Activity Score -28 joint count ) American College Rheumatology ( ACR ) response criterion , include tender swell 28 joint count , physician patient global assessment , morning stiffness pain collect study visit enable comparison composite disease activity score ( e.g . remission ) response criterion . disease activity score ( DAS ) -28 erythrocyte sedimentation rate ( ESR ) calculate possible , Japanese physician routinely collect ESR regular basis U.S. physician . Composite index disease activity , clinical disease activity index ( CDAI ) , DAS , ACR score may calculate element Corrona Questionnaire publication . In addition , PROs collect via instrument include EuroQol ( EQ ) -5D , health assessment questionnaire ( HAQ ) -DI , work productivity activity impairment instrument ( WPAI ) questionnaire . A primary objective registry analysis comparative safety . The registry may link registry purpose include comparative safety outcome study . The program-specific subject identifier number ( ID ) collect subject participate participate post-market surveillance study . The ID use ensure accuracy safety reporting regulator reduce duplicate report Note study submit United States institutional review board . It approve Japanese Authorities .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>The subject must diagnose rheumatoid arthritis accord 1987 ACR ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria The subject must least 18 year age older The subject must able willing provide write consent The subject must prescribe switch eligible medication first time ever Enrollment Visit . History concomitant treatment eligible medication exclude subject enrollment . The subject unable unwilling provide inform consent participate registry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>